Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?

Gilead Sciences, Inc. (GILD), headquartered in Foster City, California, with a market cap of $115.3 billion, is a global leader in biopharmaceutical innovation. Known for its expertise in antiviral therapies, oncology, and other critical therapeutic areas, Gilead is dedicated to advancing health outcomes, driving medical breakthroughs, and addressing unmet medical needs worldwide.

Companies valued at over $10 billion are typically classified as “large-cap stocks,” a category that Gilead Sciences exemplifies through its remarkable scale, innovation, and industry leadership.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.